l General Information |
Product Name | Salmeterol xinafoate |
General description | Salmeterol xinafoate is a selective β2-adrenergic receptor agonist with anti-inflammatory effects. |
Synonym | (±) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol xinafoate; GR 33343X xinafoate |
Purity | ≥98%(HPLC) | CAS Number | 94749-08-3 |
Formula | C25H37NO4 · C11H8O3 | Molecular Weight | 603.75 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or Off-white solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | ~4mg/mL |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | Salmeterol xinafoate is a β2 adrenoceptor agonist with longer lasting bronchodilation and anti inflammatory effects. It relaxes the airway smooth muscles, stabilizes mast cells and regulates the release of histamine. Salmetrol is particularly effective in treatment of mild asthma, chronic obstructive pulmonary disorder. |
Application | 1. Adrenergic beta-2 Receptor Agonists 2. Bronchodilator Agents |
l Packaging & Storage |
Packaging | 50mg; 250mg |
Storage temp. | 0-5℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
